Category: Announcements

NCE confirms AllerGen funding to 2019

AllerGen will receive ongoing federal funding through the Networks of Centres of Excellence (NCE) program to continue its work in allergic disease research, training and innovation to 2019. “After a review by the NCE’s international expert panel on September 17,

CHILD Study video in CIHR Competition

Update: In January 2016, the CHILD Study video was awarded first place in this competition. The CHILD Study whiteboard video is one of 13 entrants in the 2015 CIHR-“IHDCYH Talks” Video Competition. For the entire month of November, 2015, the

New report on Canadian anaphylaxis and allergic reactions in the emergency department

How many Canadians visit emergency departments (ED) each year due to allergic reactions and anaphylaxis? Are the numbers growing? Which months are the most common for anaphylactic emergencies? How have prescription patterns for epinephrine auto-injectors changed over time? A new

AllerGen researchers appointed to Hydra Biosciences Advisory Board

AllerGen research leader Dr. Paul O’Byrne has been appointed to the newly created Pulmonary Medical Advisory Board of Hydra Biosciences, a Massachusetts-based biopharmaceutical company that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease. Dr. O’Byrne, a

AllerGen team measures air quality for PanAm Games

In partnership with AllerGen, for the past four years Dr. Greg Evans and his research team at the University of Toronto have been developing “AirSENCE,” a novel technology for monitoring air quality. Their work is now going public in a high-profile

BC-based asthma study recruiting participants

A new study assessing whether text messages between patients and pharmacists in British Columbia can help patients with their asthma medication plan is looking for participants. The EmPhAsIS (Empowering Pharmacists in Asthma management through Interactive SMS) study is a 12-month

Canadian allergists recommend early peanut introduction for “high risk” infants

A new consensus communication—issued jointly by Canadian, American and European allergists and the World Allergy Organization—recommends introducing peanut-containing products into the diet of “high risk” infants between four and 11 months of age. The Canadian Society of Allergy & Clinical

“Clearing the Air” on World Asthma Day

AllerGen partner organization the Asthma Society of Canada is holding the event “Clearing the Air: Asthma and Allergies in a Time of Climate Change” on May 4 and 5, 2015, in Toronto, ON, to coincide with World Asthma Day. Motivated

Scientific Director speaks at UBC Biomedical Research Centre

AllerGen Scientific Director Dr. Judah Denburg will speak on the topic of “In situ hemopoiesis in allergic inflammation and disease: from serendipity to prediction” as part of the Biomedical Research Centre Seminar Series of The University of British Columbia (UBC).

AllerGen investigator Dr. Bruce Mazer assumes new role at McGill University Health Centre (MUHC)

Dr. Bruce Mazer has been named the Deputy Executive Director/Deputy Chief Scientific Officer of the Research Institute of the McGill University Health Centre (RI-MUHC) and Head of Child Health Research at the Montreal Children’s Hospital (MCH) of the McGill University

The Personalized Medicine Revolution

In his new book “The Personalized Medicine Revolution: How Diagnosing and Treating Disease Are About to Change Forever” (Greystone Books), Dr. Pieter Cullis explains how healthcare tailored to each individual’s unique molecular makeup will cut costs, reduce adverse drug reactions, and

HQP Video Competition

More information

Top